SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE I/II DATA AND REGULATORY UPDATE FOR LX2020 IN PKP2 ARRHYTHMOGENIC CARDIOMYOPATHY AND REP

LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE I/II DATA AND REGULATORY UPDATE FOR LX2020 IN PK

LXEO

Related stories